Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Concert Pharmaceuticals, Inc. CNCE
$8.37
На 18:00, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
401949162.00000000
-
week52high
8.55
-
week52low
2.72
-
Revenue
32545422
-
P/E TTM
-5
-
Beta
0.52051900
-
EPS
-3.17000000
-
Last Dividend
0.00000000
-
Next Earnings Date
02 авг 2023 г. в 12:30
Описание компании
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and Processa Pharmaceuticals. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| JonesTrading | Buy | 25 авг 2022 г. | |
| Mizuho | Buy | Buy | 05 окт 2021 г. |
| Truist Securities | Buy | Buy | 02 февр 2021 г. |
| Berenberg | Buy | 16 дек 2020 г. | |
| H.C. Wainwright | Buy | 03 окт 2019 г. | |
| Truist Securities | Buy | Buy | 13 сент 2022 г. |
| JonesTrading | Hold | Buy | 20 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Munsie Jeffrey A | D | 91811 | 8493 | 30 янв 2023 г. |
| Stuart Nancy | D | 268644 | 13200 | 30 янв 2023 г. |
| Becker Marc A. | D | 127625 | 8493 | 30 янв 2023 г. |
| Cassella James V | D | 176823 | 10106 | 30 янв 2023 г. |
| Tung Roger D | D | 971018 | 9240 | 06 янв 2023 г. |
| Stuart Nancy | D | 281844 | 2893 | 06 янв 2023 г. |
| Becker Marc A. | D | 136118 | 2893 | 06 янв 2023 г. |
| Cassella James V | D | 186929 | 2893 | 06 янв 2023 г. |
| Munsie Jeffrey A | D | 100304 | 2893 | 06 янв 2023 г. |
| HUTT PETER BARTON | D | 0 | 3539 | 14 окт 2022 г. |
Новостная лента
Concert Pharmaceuticals: Negative Spread But Interesting CVR
Seeking Alpha
16 февр 2023 г. в 13:54
Concert Pharmaceuticals, Inc. is a biotech buyout trading at a negative spread but with an interesting CVR attached. The CVR is based on two sales milestones.
Concert (CNCE) Stock Up 17% Last Week on Sun Pharma Buyout Offer
Zacks Investment Research
23 янв 2023 г. в 11:17
Concert Pharmaceuticals (CNCE) enters into a definitive agreement to be acquired by India-based Sun Pharmaceutical for $576 million. Stock up 17% in the previous week.
Why Concert Pharmaceuticals Stock Rocketed Higher This Week
The Motley Fool
20 янв 2023 г. в 18:15
The company is changing hands in a deal worth at least $576 million.
Concert Pharmaceuticals, Inc. (CNCE) Q3 2022 Earnings Call Transcript
Seeking Alpha
07 ноя 2022 г. в 09:58
Concert Pharmaceuticals, Inc. (NASDAQ:CNCE ) Q3 2022 Earnings Conference Call November 7, 2022 8:30 AM ET Company Participants Justine Koenigsberg - Senior Vice President, Corporate Communications and Investor Relation Roger Tung - President and Chief Executive Officer Marc Becker - Chief Financial Officer James Cassella - Chief Development Officer Nancy Stuart - Chief Operating Officer Conference Call Participants Maury Raycroft - Jefferies Leszek Sulewski - Truist Sean Kim - JonesTrading Jason Butler - JMP Securities Operator Good day and thank you for standing by. And welcome to Concert Pharmaceuticals Third Quarter 2022 Investor Call.
Concert Pharmaceuticals (CNCE) Reports Q3 Loss, Misses Revenue Estimates
Zacks Investment Research
07 ноя 2022 г. в 09:50
Concert (CNCE) delivered earnings and revenue surprises of 1.69% and 97.58%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?